News
In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...
The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...
Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...
Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...
Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...
After settlements with Zantac cancer victims in California, litigants prepare for next phase in the litigation involving over 70,000 cases The FDA pulled Zantac because it contained a potent ...
After settlements with Zantac cancer victims in California, litigants prepare for next phase in the litigation involving over 70,000 cases The FDA pulled Zantac because it contained a potent ...
Delaware's attorney general is hiring an investment bank to advise on OpenAI's for-profit conversion, the Wall Street Journal reported.
Wisner Baum and Moore Law Group Judge Vivian Medinilla found plaintiffs’ experts’ opinions admissible, paving way for over 72,000 cancer victims to have their day in Delaware Superior Court ...
GlaxoSmithKline on Tuesday said it is recalling the popular heartburn medicine Zantac in all markets as a 'precaution,' days after the U.S. Food and Drug Administration found 'unacceptable' levels ...
British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a new lawsuit has claimed.
Shares in GSK, Sanofi and Haleon were higher in early trading, recouping some of the heavy losses of the past few days, after the companies responded to recent comments related to Zantac ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results